NHI Announces Third Quarter 2020 Earnings Release and Conference Call Date

MURFREESBORO, TN / ACCESSWIRE / October 9, 2020 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2020. NHI plans to issue its earnings release after the market closes on Monday, November 9, 2020, and will host a conference call on the following day, Tuesday, November 10, 2020, at 12 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (800) 754-1391, with the confirmation number 21970511.

The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/38004 on Tuesday, November 10, 2020, at 12 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.

About NHI

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.

Contact: Dana Hambly
Director, Investor Relations
Phone: (615) 890-9100

SOURCE: National Health Investors via EQS Newswire

View source version on accesswire.com:
https://www.accesswire.com/609912/NHI-Announces-Third-Quarter-2020-Earnings-Release-and-Conference-Call-Date

Staff

Recent Posts

FendX Announces Fifth Real-World Testing Site for REPELWRAP(TM) Film with New Vista Society, a Long-Term Care and Senior Housing Provider

Testing nanotechnology to assess for further optimization of manufacturing process at DunmoreOakville, Ontario--(Newsfile Corp. -…

1 hour ago

Alzheon Raises $100 Million Series E Financing Round to Advance Development and Commercialization of Oral Tablet ALZ-801/Valiltramiprosate for Treatment of Alzheimer’s Disease

Proceeds Will Support Completion of Pivotal APOLLOE4 Phase 3 Study Evaluating ALZ-801/Valiltramiprosate and Regulatory Filings…

2 hours ago

Twenty Percent Of The World’s Employees Experience Loneliness While Global Employee Engagement Stagnated And Employee Wellbeing Declined

WASHINGTON, June 12, 2024 /PRNewswire/ -- Gallup's latest State of the Global Workplace report finds that…

2 hours ago

Alida Biosciences Announces Series A Funding and Early Access Launch of Innovative Products for Epitranscriptomic Research

SAN DIEGO, June 12, 2024 /PRNewswire/ -- Alida Biosciences (AlidaBio), an innovator in epigenomic research tools,…

2 hours ago

ScandiNova joins the United Nations Global Compact

UPPSALA, Sweden, June 12, 2024 /PRNewswire/ -- ScandiNova Group is proud to announce its participation…

2 hours ago